Systemic Juvenile Idiopathic Arthritis and Adult-onset Still's Disease Are the Same Disease: Evidence from Systematic Reviews and Meta-analyses Informing the 2023 EULAR/PReS Recommendations for the Diagnosis and Management of Still's Disease

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 2024 Sep 24

PMID 39317414

Authors

Arianna De Matteis

Sara Bindoli

Fabrizio De Benedetti

Loreto Carmona

Bruno Fautrel

Stephane Mitrovic

Affiliations

Soon will be listed here.

Abstract

Objectives: To analyse the similarity in clinical manifestations and laboratory findings between systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease (AOSD).

Methods: Three systematic reviews (SR) were performed. One included cohort studies comparing sJIA versus AOSD that described clinical and biological manifestations with at least 20 patients in each group (SR1). The second identified studies of biomarkers in both diseases and their diagnostic performance (SR2). The last focused on diagnostic biomarkers for macrophage activation syndrome (MAS, SR3). Medline (PubMed), Embase and Cochrane Library were systematically searched. The risk of bias was assessed with an adapted form of the Hoy scale for prevalence studies in SR1 and the Quality Assessment of Diagnostic Accuracy Studies-2 in SR2 and SR3. We performed meta-analyses of proportions for the qualitative descriptors.

Results: Eight studies were included in SR1 (n=1010 participants), 33 in SR2 and 10 in SR3. The pooled prevalence of clinical manifestations did not differ between sJIA and AOSD, except for myalgia, sore throat and weight loss, which were more frequent in AOSD than sJIA because they are likely ascertained incompletely in sJIA, especially in young children. Except for AA amyloidosis, more frequent in sJIA than AOSD, the prevalence of complications did not differ, nor did the prevalence of biological findings. Ferritin, S100 proteins and interleukin-18 (IL-18) were the most frequently used diagnostic biomarkers, with similar diagnostic performance. For MAS diagnosis, novel biomarkers such as IL-18, C-X-C motif ligand 9, adenosine deaminase 2 activity and activated T cells seemed promising.

Conclusion: Our results argue for a continuum between sJIA and AOSD.

Prospero Registration Number: CRD42022374240 and CRD42024534021.

Citing Articles

Patients with Adult-Onset Still's Disease in Germany: A Retrospective Analysis of Clinical Characteristics and Treatment Practices Ahead of the Release of the German Recommendations.

Schoenau V, Wendel S, Tascilar K, Henes J, Feist E, Baerlecken N J Clin Med. 2025; 14(3).

PMID: 39941651 PMC: 11818083. DOI: 10.3390/jcm14030981.

Early identification of macrophage activation syndrome in adult-onset Still's disease: a case report and literature review.

Long T, Xu J, Lin B, Li S Front Med (Lausanne). 2025; 12:1498928.

PMID: 39931557 PMC: 11808000. DOI: 10.3389/fmed.2025.1498928.

Uncertainty in the diagnosis and prognosis of adult-onset Still's disease.

Pannu A Biomark Med. 2025; 19(4):101-103.

PMID: 39873352 PMC: 11834521. DOI: 10.1080/17520363.2025.2459591.

EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease.

Fautrel B, Mitrovic S, De Matteis A, Bindoli S, Anton J, Belot A Ann Rheum Dis. 2024; 83(12):1614-1627.

PMID: 39317417 PMC: 11672000. DOI: 10.1136/ard-2024-225851.

References

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

Lee J, Schneider R . Systemic Juvenile Idiopathic Arthritis. Pediatr Clin North Am. 2018; 65(4):691-709. DOI: 10.1016/j.pcl.2018.04.005. View

Javaux C, El-Jammal T, Neau P, Fournier N, Gerfaud-Valentin M, Perard L . Detection and Prediction of Macrophage Activation Syndrome in Still's Disease. J Clin Med. 2022; 11(1). PMC: 8745834. DOI: 10.3390/jcm11010206. View

Rau M, Schiller M, Krienke S, Heyder P, Lorenz H, Blank N . Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis. J Rheumatol. 2010; 37(11):2369-76. DOI: 10.3899/jrheum.100247. View

Petty R, Southwood T, Manners P, Baum J, Glass D, Goldenberg J . International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004; 31(2):390-2. View

Koga T, Sumiyoshi R, Furukawa K, Sato S, Migita K, Shimizu T . Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still's disease from sepsis. Arthritis Res Ther. 2020; 22(1):108. PMC: 7206754. DOI: 10.1186/s13075-020-02200-4. View

Coulson E, Hanson H, Foster H . What does an adult rheumatologist need to know about juvenile idiopathic arthritis?. Rheumatology (Oxford). 2014; 53(12):2155-66. DOI: 10.1093/rheumatology/keu257. View

Sagy I, Finkel-Oron A, Naamany E, Barski L, Abu-Shakra M, Molad Y . Diagnostic utility of clinical characteristics, laboratory tests, and serum ferritin in diagnosis of adult-onset Still disease. Medicine (Baltimore). 2022; 101(34):e30152. PMC: 9410682. DOI: 10.1097/MD.0000000000030152. View

Kostik M, Dubko M, Masalova V, Snegireva L, Kornishina T, Chikova I . Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis. Semin Arthritis Rheum. 2014; 44(4):417-22. DOI: 10.1016/j.semarthrit.2014.09.004. View

10.

De Matteis A, Colucci M, Rossi M, Caiello I, Merli P, Tumino N . Expansion of CD4dimCD8+ T cells characterizes macrophage activation syndrome and other secondary HLH. Blood. 2022; 140(3):262-273. DOI: 10.1182/blood.2021013549. View

11.

Ahn S, Yoo B, Jung S, Lee S, Park Y, Song J . Application of the 2016 EULAR/ACR/PRINTO Classification Criteria for Macrophage Activation Syndrome in Patients with Adult-onset Still Disease. J Rheumatol. 2017; 44(7):996-1003. DOI: 10.3899/jrheum.161286. View

12.

Jamilloux Y, Georgin-Lavialle S, Seve P, Belot A, Fautrel B . [It is time to reconcile systemic juvenile idiopathic arthritis and adult-onset Still's disease]. Rev Med Interne. 2019; 40(10):635-636. DOI: 10.1016/j.revmed.2019.06.001. View

13.

Chaturvedi V, Marsh R, Zoref-Lorenz A, Owsley E, Chaturvedi V, Nguyen T . T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis. Blood. 2021; 137(17):2337-2346. PMC: 8085480. DOI: 10.1182/blood.2020009499. View

14.

Luo L, Zhang L, Jiang J, Ding X . Role of mean platelet volume in differential diagnosis of adult-onset Still's disease and sepsis. Rev Assoc Med Bras (1992). 2022; 67(10):1443-1447. DOI: 10.1590/1806-9282.20210649. View

15.

Gerfaud-Valentin M, Seve P, Hot A, Broussolle C, Jamilloux Y . [Pathophysiology, subtypes, and treatments of adult-onset Still's disease: An update]. Rev Med Interne. 2014; 36(5):319-27. DOI: 10.1016/j.revmed.2014.10.365. View

16.

Martini A, Ravelli A, Avcin T, Beresford M, Burgos-Vargas R, Cuttica R . Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus. J Rheumatol. 2018; 46(2):190-197. DOI: 10.3899/jrheum.180168. View

17.

Immonen K, Savolainen H, Hakala M . Why can we no longer find juvenile idiopathic arthritis-associated amyloidosis in childhood or in adolescence in Finland?. Scand J Rheumatol. 2007; 36(5):402-3. DOI: 10.1080/03009740701340339. View

18.

Inoue N, Shimizu M, Tsunoda S, Kawano M, Matsumura M, Yachie A . Cytokine profile in adult-onset Still's disease: Comparison with systemic juvenile idiopathic arthritis. Clin Immunol. 2016; 169:8-13. DOI: 10.1016/j.clim.2016.05.010. View

19.

Eloseily E, Minoia F, Crayne C, Beukelman T, Ravelli A, Cron R . Ferritin to Erythrocyte Sedimentation Rate Ratio: Simple Measure to Identify Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis. ACR Open Rheumatol. 2019; 1(6):345-349. PMC: 6857981. DOI: 10.1002/acr2.11048. View

20.

Xia Y, Cui P, Li Q, Liang F, Li C, Yang J . Extremely elevated IL-18 levels may help distinguish systemic-onset juvenile idiopathic arthritis from other febrile diseases. Braz J Med Biol Res. 2017; 50(2):e5958. PMC: 5343556. DOI: 10.1590/1414-431X20165958. View